购物车
- 全部删除
- 您的购物车当前为空
AEF0117为一种针对大麻素受体1 (CB1-SSi) 的信号传导特异性抑制剂,抑制大麻素自我给药和与四氢大麻酚相关的行为障碍,可用于研究大麻戒断。
为众多的药物研发团队赋能,
让新药发现更简单!
AEF0117为一种针对大麻素受体1 (CB1-SSi) 的信号传导特异性抑制剂,抑制大麻素自我给药和与四氢大麻酚相关的行为障碍,可用于研究大麻戒断。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 198 | 现货 | |
5 mg | ¥ 448 | 现货 | |
10 mg | ¥ 713 | 现货 | |
25 mg | ¥ 1,430 | 现货 | |
50 mg | ¥ 2,290 | 现货 | |
100 mg | ¥ 3,760 | 现货 | |
500 mg | ¥ 7,900 | 现货 |
产品描述 | AEF0117, a signaling-specific inhibitor of cannabinoid receptor 1 (CB1-SSi), inhibits cannabinoid self-administration and behavioral disorders associated with THC, and can be used to study cannabis withdrawal. |
分子量 | 436.63 |
分子式 | C29H40O3 |
CAS No. | 1610878-71-1 |
Smiles | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@H](C(C)=O)CC4)[H])(CC=C1C[C@@H](OCC5=CC=C(OC)C=C5)CC2)[H])[H] |
存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | DMSO: 3.12 mg/mL (7.16 mM), Sonication is recommended. ![]() H2O: <1 mg/mL (Insoluble) ![]() | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
|
评论内容